Skip to content
WHO report warns of the rise in antibiotic resistance, seeks better data
Common bacterial infections are becoming increasingly resistant to antibiotics, “causing life-threatening bloodstream infections,” ...
Read More
Mexico’s treatment of biotech corn needs urgent action, U.S. lawmakers say
Ahead of a key meeting between the U.S. and Mexico later this week, ...
Read More
Takeda’s dengue vaccine approved for use in the EU
Takeda announced the European Commission (EC) authorized the company’s new dengue vaccine for ...
Read More
U.S. punts decision on COVID IP waiver to 2023
Could the Office of the U.S. Trade Representative’s (USTR) position on the COVID ...
Read More
Bivalent COVID boosters are available – here’s why you should get one
The Centers for Disease Control and Prevention (CDC) has released new data demonstrating ...
Read More
How Dobbs v. Jackson is affecting vaccine innovation
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO Events
PACE: Downstream effects of IRA on patients
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates and the biotech industry are working to navigate downstream negative impacts on ...
Federal Policy
PACE panel urges incentives for exciting new GTT drugs
Luke Rosen had hoped a new treatment would slow the progression of his daughter’s KIF1A Associated Neurological Disorder (KAND), but was amazed to see an ...
BIO Events
PACE: How 340B outgrew its goal and stopped helping patients
The 340B program, in recent decades, has shown how the best laid plans can go sideways when not kept transparent and properly in check. Initially ...
Federal Policy
BIO CEO John Crowley tells Senate how to support biotech
Maintaining America’s biotechnology leadership requires Food and Drug Administration (FDA) modernization as well as Congressional action to reauthorize a program supporting rare disease research and ...
Health
A legacy of love, leadership, and liberation: Tigerlily’s next chapter
October is Breast Cancer Awareness Month, and to mark the occasion, Bio.News has partnered with the Tigerlily Foundation to explore how they developed their advocacy. ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO PACE 2025: Patients need to ensure state policies enable access to medicine
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures ...
Read More
International
Bio's View
Putting Americans First: Importing European prices means importing European systems and values
European countries don’t just pull prices for medicines out of thin air. The prices that those governments set are based ...
Read More
